deltatrials

Chronic myelogenous leukemia Trials in Houston, United States

Conditions / Chronic myelogenous leukemia / Houston, United States

Research into Chronic myelogenous leukemia spans multiple therapeutic approaches and trial phases.

36 total trials for this combination

Showing top 10 of 36 trials

Trials

NCT ID Title Status Phase
NCT03106779 Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs COMPLETED PHASE3
NCT04904588 HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide ACTIVE_NOT_RECRUITING PHASE2
NCT00101647 Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia COMPLETED PHASE2
NCT04877522 Asciminib Roll-over Study RECRUITING PHASE4
NCT00852709 Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias TERMINATED PHASE1
NCT02208037 Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) COMPLETED PHASE2
NCT00579111 Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) TERMINATED PHASE1/PHASE2
NCT00109707 A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies COMPLETED PHASE1/PHASE2
NCT06131801 Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution RECRUITING
NCT00333840 Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia COMPLETED PHASE3

Related Pages